METIMMOX-1 economic eval of biomarker-guided immunotherapy in MSS/pMMR met. colorectal cancer
biomarker ridge-regression mss biomarkers health-economics prognostic-biomarkers economic-evaluation cost-effectiveness-analysis colorectal-cancer predictive-biomarkers predictive-biomarker metimmox metimmox-1 pmmr metastatic-cancer firth-regression prognostic-biomarker
-
Updated
Oct 9, 2026 - R